A Study of ZL-1211 in Patients With Advanced Solid Tumor

NCT05065710 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: ZL-1211

Sponsor

Zai Biopharmaceutical (Suzhou) Co., Ltd.